tiprankstipranks
Arjo AB Class B (ARRJF)
OTHER OTC:ARRJF

Arjo AB (ARRJF) Price & Analysis

4 Followers

ARRJF Stock Chart & Stats

$3.50
-$0.40(-11.64%)
At close: 4:00 PM EST
$3.50
-$0.40(-11.64%)

Bulls Say, Bears Say

Bulls Say
Recurring Aftermarket RevenueA large portion of sales comes from service, maintenance, parts and consumables tied to an installed base, creating recurring revenue. This durable mix smooths cyclical capital spending, supports steady cash flow and increases lifetime customer value over multiple years.
Manageable Leverage & Solid Equity BaseLeverage at ~0.68 and a near-50% equity ratio provide financial flexibility to fund investments, sustain operations and absorb shocks. This balance sheet profile supports sustained capex, working-capital needs and dividend policy without excessive refinancing risk.
Improving Operational Cash And Growth MetricsRecent quarters show durable operational improvement: healthy organic growth, margin uptick and materially better cash conversion. If sustained, these trends indicate stronger earnings quality and cash-earnings linkage, aiding deleveraging and supporting reinvestment or shareholder returns.
Bears Say
Thin And Compressed MarginsProfitability is structurally thin and has deteriorated versus prior years, limiting reinvestment capacity and sensitivity to cost shocks. Persistent low margins reduce resilience to price pressure or higher costs and constrain the company's ability to build significant excess returns long term.
Declining Free Cash Flow TrendA near‑15% decline in trailing free cash flow signals weaker cash conversion trends and tighter internal funding for growth or dividends. Persistent FCF deterioration makes strategic investments or debt paydown more dependent on margin recovery and working-capital management.
Working Capital And Inventory BuildRising working capital days and in‑transit inventory tie up liquidity and amplify FCF volatility. If inventories and receivables remain elevated through sales cycles, the company will face ongoing cash strain and greater sensitivity to supply-chain timing and demand variability.

Arjo AB News

ARRJF FAQ

What was Arjo AB Class B’s price range in the past 12 months?
Arjo AB Class B lowest stock price was $2.32 and its highest was $3.95 in the past 12 months.
    What is Arjo AB Class B’s market cap?
    Arjo AB Class B’s market cap is $739.85M.
      When is Arjo AB Class B’s upcoming earnings report date?
      Arjo AB Class B’s upcoming earnings report date is Oct 22, 2026 which is in 88 days.
        How were Arjo AB Class B’s earnings last quarter?
        Arjo AB Class B released its earnings results on Jul 14, 2026. The company reported $0.048 earnings per share for the quarter, beating the consensus estimate of $0.043 by $0.005.
          Is Arjo AB Class B overvalued?
          According to Wall Street analysts Arjo AB Class B’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
            Does Arjo AB Class B pay dividends?
            Arjo AB Class B pays a Annually dividend of $0.103 which represents an annual dividend yield of 3.5%. See more information on Arjo AB Class B dividends here
              What is Arjo AB Class B’s EPS estimate?
              Arjo AB Class B’s EPS estimate is 0.04.
                How many shares outstanding does Arjo AB Class B have?
                Arjo AB Class B has 254,152,370 shares outstanding.
                  What happened to Arjo AB Class B’s price movement after its last earnings report?
                  Arjo AB Class B reported an EPS of $0.048 in its last earnings report, beating expectations of $0.043. Following the earnings report the stock price went down -1.625%.
                    Which hedge fund is a major shareholder of Arjo AB Class B?
                    Currently, no hedge funds are holding shares in ARRJF
                    What is the TipRanks Smart Score and how is it calculated?
                    Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

                      Company Description

                      Arjo AB Class B

                      Arjo AB (publ) is a global leader in providing medical devices and innovative solutions tailored for patients experiencing limited mobility and age-related health conditions. Operating across North America, Western Europe, and other international markets, the company's comprehensive offerings span safe patient handling, hygiene and disinfection products, specialized medical beds, and technologies for the prevention and treatment of pressure injuries, leg ulcers, deep vein thrombosis, and edema. They also supply equipment for obstetric and cardiac diagnostics. Complementing its product range, Arjo delivers valuable services such as specialized room assessments for dementia and bariatric care, clinical consulting, equipment maintenance, and flexible rental and financing options. Their diverse client base comprises both private and public institutions engaged in acute and long-term healthcare. Founded in 1957, Arjo AB (publ) is headquartered in Malmö, Sweden.

                      Arjo AB (ARRJF) Earnings & Revenues

                      ARRJF Company Deck

                      ARRJF Earnings Call

                      Q2 2026
                      0:00 / 0:00
                      Earnings Call Sentiment|Positive
                      The call presented a mix of encouraging operational and financial improvements—solid organic growth (4.7%), record ReNu sales, slight increases in adjusted EBIT and EBITDA, improved cash flow and cash conversion, and a robust equity ratio—while also highlighting meaningful margin pressures from transportation and material costs, product/country mix effects, price erosion in specific segments, and weaker U.S. rental profitability. Management is taking governance and strategic steps (regional leaders, Capital Markets Day) to drive value creation. On balance, the positives (growth, cash improvement, margin discipline, strategic actions) modestly outweigh the negatives (cost and margin headwinds), supporting a cautiously positive view.View all ARRJF earnings summaries
                      Similar Stocks
                      Company
                      Price & Change
                      Follow
                      Elekta AB
                      Vitrolife AB
                      AddLife AB
                      BONESUPPORT HOLDING AB
                      MedCap AB

                      Ownership Overview

                      5.10%89.81%
                      Insiders
                      ― Other Institutional Investors
                      89.81% Public Companies and
                      Individual Investors
                      Popular Stocks